Low-cost optical sensing for healthcare
Discussion meeting organised by Professor Jeremy J Baumberg FRS and Professor Duncan Graham
The increasing emergence of novel optical sensors which operate at the nanoscale opens tantalising opportunities for low-cost paradigms in data-rich sensing that can impact Healthcare. Here we focus on continuous biochemical information (‘BioSensors 2.0’) which go far beyond currently physiological wearable or diagnostic sensors to probe information on health across a variety of settings, and ask which modalities can succeed.
Programme
The programme, including speaker biographies and abstracts, is available below. Please note that the programme may be subject to change.
Poster session
There will be a poster session on Monday 9 November 2026. If you would like to present a poster, please submit your proposed title, abstract (up to 200 words), author list, and the name of the proposed presenter and institution no later than Friday 9 October 2026. Acceptances may be made on a rolling basis so we recommend submitting as soon as possible in case the session becomes full. Submissions made within one month of the meeting may not be included in the programme booklet.
Attending the event
This event is intended for researchers in relevant fields.
- Free to attend
- Both virtual and in-person attendance is available. Advance registration is essential
- Lunch is available on both days of the meeting for an optional £25 per day. There are plenty of places to eat nearby if you would prefer to purchase food offsite. Participants are welcome to bring their own lunch to the meeting
Please note that scientific meetings hosted by the Royal Society do not necessarily represent a Royal Society position or signify an endorsement of the speakers or content presented.
Enquiries: contact the Scientific Programmes team
Organisers
Schedule
Chair
Professor Jeremy Baumberg FRS
University of Cambridge, UK
Professor Jeremy Baumberg FRS
University of Cambridge, UK
Professor Jeremy J Baumberg FRSC FRS is the Harald Aspden Professor of Fundamental Physics at the University of Cambridge, directing a key UK NanoPhotonics Centre. He develops optical materials structured on the nanoscale, with strong experience at Hitachi, IBM, and his spin-offs combining academic insight with translation. He is a leading innovator in Nano (h-120), leading to awards including the IoP Faraday gold Medal (2017) and Royal Society Rumford Medal (2014). He is currently chair of the UK EPSRC Council. His recent popular science book “The Secret Life of Science: How Science Really Works and Why it Matters” focusses on research culture. (https:\\np.phy.cam.ac.uk).
| 09:00-09:05 |
Welcome by the Royal Society and lead organiser
Professor Jeremy Baumberg FRSUniversity of Cambridge, UK
Professor Jeremy Baumberg FRSUniversity of Cambridge, UK Professor Jeremy J Baumberg FRSC FRS is the Harald Aspden Professor of Fundamental Physics at the University of Cambridge, directing a key UK NanoPhotonics Centre. He develops optical materials structured on the nanoscale, with strong experience at Hitachi, IBM, and his spin-offs combining academic insight with translation. He is a leading innovator in Nano (h-120), leading to awards including the IoP Faraday gold Medal (2017) and Royal Society Rumford Medal (2014). He is currently chair of the UK EPSRC Council. His recent popular science book “The Secret Life of Science: How Science Really Works and Why it Matters” focusses on research culture. (https:\\np.phy.cam.ac.uk). |
|---|---|
| 09:05-09:30 |
Interferometric sensing of proteins and miRNA
Professor Selim UnluBoston University, US Professor Selim UnluBoston University, US |
| 09:30-09:45 |
Discussion
|
| 09:45-10:15 |
Surface plasmon resonance sensors for point-of-need applications
Accessing diagnostic tests in northern communities of Canada faces many challenges as they are only accessed by flight and most communities do not have clinical laboratories. Samples must therefore be shipped nearly 4000 km to be analysed in a major metropolitan area. Over the next few decades, human beings will be called upon to travel outside the Earth's magnetosphere on extended missions to the Moon and Mars. These journies will increase exposure to cosmic radiation, and thus the potential for radiation-induced disease. In both examples, inflammation markers monitoring is of importance as they correlate with a range of pathologies from infection to cancer. We are developing a small, portable instrument based on surface plasmon resonance and microfluidics to measure a panel of inflammation markers from a drop of blood. The concept is based on a disposable cartridge in which the drop of blood reacts with the surface of the device, and for which the concentration of markers is revealed by reagents inserted in the cartridge. The presentation will showcase the technological advances made to date, and demonstrate the technology's potential for health monitoring of inhabitants of remote communities and for astronauts.
Professor Jean-François MassonUniversity of Montreal, Canada
Professor Jean-François MassonUniversity of Montreal, Canada Jean-François Masson is full professor of Chemistry and head of the Department of chemistry at the Université de Montréal. His laboratory develops new plasmonic materials, instruments, and surface chemistry for the detection of broad range of molecules directly in crude samples, which are then translated to functional sensors for a series of biological, environmental and industrial applications. He has published more than 150 research articles and his research has led to filing more than 10 patents on various instrumental, materials or surface chemistry innovations for biosensing. In 2015, he co-founded Affinité Instruments, a Canadian start-up company commercializing surface plasmon resonance (SPR) instrumentation. Jean-François received several awards including the McBryde Medal of the Canadian Society for Chemistry, and an Alexander von Humboldt fellowship, Germany for research at the Max-Planck Institute. In 2017, he was named Fellow of the Royal Society of Chemistry – UK. |
| 10:15-10:30 |
Discussion
|
| 10:30-11:00 |
Break
|
| 11:00-11:30 |
Low-cost fluorometric sensing for microbial contamination of water
Traditional microbiological water-testing assays based on culturing are severely constrained by a long time to result, high consumable costs, and need for skilled personnel, leaving nearly half of the global population without regular water-safety monitoring. To bridge this diagnostic gap, we present a low-cost, field-deployable fluorometry platform designed for the rapid, high-sensitivity detection of microbial contamination. Our test is based on Tryptophan-Like Fluorescence (TLF) (Ex/Em 275 nm/350 nm) which is a known proxy for microbial activity. The utility of TLF is limited by its poor specificity and overlapping background interferents, however. We overcome this limitation by accounting for radiative and non-radiative energy transfer pathways, resolving the multi-component fluorescent profiles of native aquatic fluorophores to map fluorescence signatures among co-localized biomolecules. Tracking these interactions yields a highly specific spectral fingerprint that isolates target bacterial signatures from abiotic background noise. Our platform represents the first sensing methodology that is able to meet UNICEF's target product profile (TPP) for drinking water monitoring. To transition our technology into a handheld form factor, we have revisited the foundational radiometric principles of water sensing, re-engineering our optical setup into a novel, lensless and filterless multiparameter sensing architecture. By employing off-the-shelf LED arrays and silicon photodetectors coupled with custom transimpedance amplifiers, we achieve sensitivities comparable to commercial instruments at a fraction of the cost. To maximize the societal benefit, we are engaging several communities in Nepal, which is essential for comprehending our specific challenges and devising locally appropriate solutions.
Dr Ashim DhakalPhutung Research Institute, Nepal
Dr Ashim DhakalPhutung Research Institute, Nepal Ashim Dhakal is the Managing Director and Head of the Biophotonics Lab at Phutung Research Institute in Nepal. He earned an Erasmus Mundus MSc in Photonics Engineering across a consortium of European and UK universities, followed by a PhD in Photonics Engineering from Ghent University – imec. Dr Dhakal is a co-inventor of nanophotonic waveguide-enhanced Raman spectroscopy, a foundational technology leveraging evanescent fields for high-sensitivity spectroscopy that is now widely pursued by research groups and commercial startups globally for photonic integrated circuit (PIC) based Raman sensing. Driven by the conviction that science, technology, and innovation are the cornerstones of social development, he returned to Nepal to establish Phutung Research Institute as a hub for advanced research. His expertise spans advanced spectroscopy, silicon/silicon nitride integrated photonics, and optical coherence tomography. A Royal Academy of Engineering International Associate (2024), his work has been recognised through numerous awards and invited/keynote presentations at flagship international conferences, including CLEO and SPIE Photonics West. |
| 11:30-11:45 |
Discussion
|
| 11:45-12:15 |
Electrochemical biosensors and biodevices for medical diagnosis and (waste)water monitoring
There is a great need for low-cost biosensor chips capable of massive parallel detection to be used in portable instrumentation. Biosensors have a number of very important applications in everyday life including diagnostics for disease detection and monitoring, viral and bacterial identification, detection of contaminants in the environment, detection of biowarfare agents, etc. To have a wide use in applications, biosensors need to provide a combination of high selectivity and sensitivity, speed, low cost and portability. Electrochemical methods are inherently low-cost, miniaturisable and easily integrated into multiplexed systems for the parallel screening of panels of biomarkers. Of particular interest are biologically sensitive field-effect transistors (BioFETs) and impedance-based sensors. Improved selectivity and robustness can be provided by using synthetic molecules such as DNA aptamers, peptide aptamers and molecularly imprinted polymers as alternatives to antibodies, as well as oligonucleotide-based approaches in biosensors for the detection of a range of biomarkers in medical diagnosis and for water/wastewater monitoring. We will exemplify the use of BioFETs, Faradaic and non-Faradaic impedance for the detection of a range of biomarkers in medical diagnosis and for water/wastewater monitoring. Such biosensors can be integrated with microfluidics and electronic addressing for on-chip sample preparation, sensing and data transmission in fully functional Lab-on-Chip biodevices for point-of-care applications.
Professor Pedro EstrelaBath University, UK
Professor Pedro EstrelaBath University, UK Pedro Estrela is Professor of Biosensors and Bioelectronics at the Department of Electronic & Electrical Engineering and Director of the Centre for Bioengineering & Biomedical Technologies (CBio), University of Bath. He has a background in Physics (degree and Masters from the University of Lisbon, PhD from the University of Amsterdam) and started working in the field of biosensors in 2000 (University of Cambridge until 2008 and University of Bath since 2008). He is Co-Director of the Research England funded Centre of Excellence in Water-Based Early-Warning Systems for Health Protection, Co-Director of the NERC CDT in Real-Time Digital Water-Based Systems for Environmental Health Protection, and member of the Steering Committee of the Consortium for Precision Health. Professor Estrela’s research focuses on the development of label-free electrical, electrochemical and plasmonic biosensors and lab-on-chip devices for a wide range of applications such as medical diagnosis, prognosis and monitoring as well as water/wastewater monitoring. He is an Associate Editor for Biosensors & Bioelectronics and other journals and Specialty Chief Editor in Frontiers in Lab on a Chip Technologies. |
| 12:15-12:30 |
Discussion
|
Chair
Professor Giulia Tagliabue
École Polytechnique Fédérale de Lausanne, Switzerland
Professor Giulia Tagliabue
École Polytechnique Fédérale de Lausanne, Switzerland
Dr Giulia Tagliabue is an Associate Professor in the Department of Mechanical Engineering at EPFL where she is the head of the Laboratory of Nanoscience for Energy Technologies (LNET). She obtained her PhD in Mechanical Engineering from ETH Zurich in 2015. From 2015 to 2018 she was a Swiss National Science Foundation Fellow and she carried on her postdoctoral research jointly at Caltech and the Joint Center for Artificial Photosynthesis (JCAP). Dr Tagliabue’s research focuses on the study of fundamental mechanisms and nanophotonic-design strategies for light-energy conversion devices, with a special interest for light-energy storage systems. Dr Tagliabue is the recipient of the First Prize of the Rising Stars of Light Award 2020, the 2021 Early Career Award in Nanophotonics, the 2023 Zellner Prize in Physical Chemistry, the 2024 Daniela-Pucci Prize in Nanophotonics and the 2024 Latsis University Prize EPFL. In 2024 she also received the EPFL Best Teaching Award. In 2020 she was awarded an Eccellenza Grant from SNSF and in 2022 she received an SNSF Starting Grant. She is member of the American Chemical Society (ACS) and the Optical Society of America (Optica).
| 13:30-14:00 |
Online SERS detection
Increased understanding of surface enhanced Raman spectroscopy (SERS) has enabled new experiments and approaches for chemical specific detection that hold tremendous promise for how we monitor chemical signals, molecular indicators, and diagnose disease. Prior work in our lab has demonstrated that chemicals in solution can be monitored in an online fashion to detect changes in biochemical composition associated with disease. Diverse plasmonic surfaces show chemical specific enhancement for a wide variety of biomarkers. Challenges to utilizing SERS in clinical assays include reproducibility and quantitation. To address these challenges, we are investigating how transport to the sensor in microfluidic channel impacts detection. We have developed a sheath-flow interface for SERS detection in flow. This sheath-flow SERS interface uses hydrodynamic focusing to confine analyte molecules eluting/migrating out of a capillary onto a planar SERS substrate where the molecules are detected by their intrinsic SERS signal. This sheath-flow SERS detector can be readily incorporated for post-separation characterisation, such as with CE and HPLC. More recently we have investigated how migration in an electric field combines with sheath flow to improve detection. Additional work indicates single molecule detection is possible for molecules with large SERS cross-sections. Through control of Our work suggests a new route to identifying molecules for diagnostic and prognostic assays.
Professor Zachary SchultzOhio State University, US
Professor Zachary SchultzOhio State University, US Zachary D Schultz PhD, is a professor in the department of Chemistry and Biochemistry at The Ohio State University. Professor Schultz earned his BS degree from the Ohio State University (2000) and PhD from the University of Illinois at Urbana-Champaign (2005). Following postdoctoral studies at NIST (USA) and the NIH (USA), he began his independent career at the University of Notre Dame (2009). Professor Schultz moved to the Ohio State University in 2018. Professor Schultz has been recognised as a Cottrell Scholar (2013), as a Fellow of the American Association for the Advancement of Science (AAAS) in 2019, with the Craver Award for applied vibrational spectroscopy from the Coblentz Society (2021), and as a Fellow of the Royal Society of Chemistry (2024). Professor Schultz is an associated editor for ACS Sensors. Professor Schultz’s research focuses on using spectroscopy for label-free imaging and ultrasensitive detection. |
|---|---|
| 14:00-14:15 |
Discussion
|
| 14:15-14:45 |
SERS based multicomponent sensing
|
| 14:45-15:00 |
Discussion
|
| 15:00-15:30 |
Break
|
| 15:30-16:00 |
Optical typing of bacteria
Professor Jennifer DionneStanford University, US
Professor Jennifer DionneStanford University, US Jennifer (Jen) Dionne is a Professor of Materials Science and, by courtesy, of Radiology at Stanford. She is also deputy director of Q-NEXT (a DOE-funded National Quantum Initiative), a Chan Zuckerberg Biohub Investigator, and co-founder of Pumpkinseed, the "Biology Mining Company". Jen received her BS degrees in Physics and Systems Science and Mathematics from Washington University in St Louis, her PhD in Applied Physics at Caltech, and her postdoctoral training in Chemistry at Berkeley. As a pioneer of nanophotonics, she is passionate about developing novel methods to detect and direct biochemical transformations, emphasizing critical challenges in global health and sustainability. Her lab has demonstrated how AI-enabled Raman spectroscopy can be used to identify pathogens and predict their antibiotic resistance; and to monitor drug susceptibility of melanoma. She also forged new ground in developing in vivo tools for mechanobiology. Finally, she has pioneered environmental transmission electron microscopy, providing atomic-scale insights that enable catalysts for sustainable chemical manufacturing. Her work has been recognized with the NSF Waterman Award, a NIH Director’s New Innovator Award, a Moore Inventor Fellowship, and the Presidential Early Career Award for Scientists and Engineers, and was featured on Oprah’s list of “50 Things that will make you say ‘Wow’”. |
| 16:00-16:15 |
Discussion
|
| 16:15-17:00 |
Poster flash talk session
|
Chair
Professor Hatice Altug
École Polytechnique Fédérale de Lausanne, Switzerland
Professor Hatice Altug
École Polytechnique Fédérale de Lausanne, Switzerland
| 09:00-09:30 |
Mid-IR sensing
Professor Hatice AltugÉcole Polytechnique Fédérale de Lausanne, Switzerland Professor Hatice AltugÉcole Polytechnique Fédérale de Lausanne, Switzerland |
|---|---|
| 09:30-09:45 |
Discussion
|
| 09:45-10:15 |
ATR-FTIR liquid biopsy: From invention to clinical impact
Liquid biopsy has the potential to transform cancer detection, but many current approaches depend on low-abundance tumour-derived analytes, complex workflows and specialist laboratory infrastructure. We have developed an attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy platform as a reagent-free optical sensing approach for cancer detection from blood. ATR-FTIR captures a global biochemical fingerprint of serum or plasma, reflecting both tumour-derived signals and the systemic host response to disease. Small-volume samples are deposited, dried and analysed within minutes, generating spectra that contain information from proteins, lipids, nucleic acids, carbohydrates and metabolites. Machine-learning models are then used to identify multivariate spectral patterns associated with cancer and to distinguish these from benign or non-cancer conditions. Development has focused on analytical robustness, standardised sample handling, instrument transferability and clinically relevant validation across multiple cancer indications. Studies involving large, well-characterised cohorts have demonstrated the potential of spectral liquid biopsy to support cancer detection and clinical triage. This presentation will describe the translation pathway from academic invention to a commercially released diagnostic test. The Dxcover Brain Test will be presented as a translational case study, illustrating the progression of an ATR-FTIR liquid-biopsy platform through analytical development, clinical validation, regulatory assessment under UKCA and CE-IVDR, and implementation within UK, and US clinical laboratory pathways, including CLIA. The work will illustrate how spectroscopy can move beyond proof-of-concept into regulated clinical practice. By combining rapid analysis, minimal consumables and scalable instrumentation, ATR-FTIR liquid biopsy may broaden access to earlier diagnosis across diverse healthcare systems.
Professor Matthew J BakerUniversity of Central Lancashire, UK
Professor Matthew J BakerUniversity of Central Lancashire, UK |
| 10:15-10:30 |
Discussion
|
| 11:00-11:30 |
Colorimetric detection
Professor Charlie MaceTufts University, US Professor Charlie MaceTufts University, US |
| 11:30-11:45 |
Discussion
|
| 11:45-12:15 |
Nanophotonics for probing solid–liquid interfaces in light-driven energy devices
Nano-sized materials and nanoconfined fluids open new possibilities for controlling charge transport in both the solid and liquid phases, enabling unprecedented energy conversion pathways, including hot carrier plasmonic photochemical devices and hydrovoltaic systems. Here I will discuss how nanophotonics opens new pathways for probing charged solid-liquid interfaces towards understanding both faradaic and non-faradaic interactions and paving the way to the engineering of emerging energy conversion and storage devices. Professor Giulia TagliabueÉcole Polytechnique Fédérale de Lausanne, Switzerland Professor Giulia TagliabueÉcole Polytechnique Fédérale de Lausanne, Switzerland Dr Giulia Tagliabue is an Associate Professor in the Department of Mechanical Engineering at EPFL where she is the head of the Laboratory of Nanoscience for Energy Technologies (LNET). She obtained her PhD in Mechanical Engineering from ETH Zurich in 2015. From 2015 to 2018 she was a Swiss National Science Foundation Fellow and she carried on her postdoctoral research jointly at Caltech and the Joint Center for Artificial Photosynthesis (JCAP). Dr Tagliabue’s research focuses on the study of fundamental mechanisms and nanophotonic-design strategies for light-energy conversion devices, with a special interest for light-energy storage systems. Dr Tagliabue is the recipient of the First Prize of the Rising Stars of Light Award 2020, the 2021 Early Career Award in Nanophotonics, the 2023 Zellner Prize in Physical Chemistry, the 2024 Daniela-Pucci Prize in Nanophotonics and the 2024 Latsis University Prize EPFL. In 2024 she also received the EPFL Best Teaching Award. In 2020 she was awarded an Eccellenza Grant from SNSF and in 2022 she received an SNSF Starting Grant. She is member of the American Chemical Society (ACS) and the Optical Society of America (Optica). |
| 12:15-12:30 |
Discussion
|
Chair
Professor Duncan Graham
University of Strathclyde, UK
Professor Duncan Graham
University of Strathclyde, UK
Duncan Graham is Distinguished Professor, Associate Principal and Executive Dean of the Faculty of Science at the University of Strathclyde, Glasgow. Appointed lecturer in 2002, he was promoted to Professor in 2004 and elected Fellow of the Royal Society of Edinburgh in 2007. His awards include the RSC Corday Morgan Prize, Royal Society Wolfson Merit Award, Coblentz Society Craver Award, Society for Applied Spectroscopy Fellows Award, RSC Theophilus Redwood Award, FACSS Charles Mann Award, the 2025 RSC Interdisciplinary Prize and Honorary Lifetime Membership of the Society for Applied Spectroscopy. He served for seven years as Editor in Chief of Analyst and is now Editor in Chief of Chemical Society Reviews. From 2017 to 2020 he was President of the RSC Analytical Division and Chair of the Analytical Chemistry Trust Fund; from 2020 to 2024 he chaired the RSC Publishing Board and served as an RSC Trustee. He has published over 300 papers, holds 17 patents, and has supervised more than 70 PhD students and 40 postdoctoral researchers. His research develops nanoparticle and spectroscopy based diagnostic assays for DNA, RNA, proteins and small molecule biomarkers.
| 13:30-14:00 |
QCM aptamer sensing
|
|---|---|
| 14:00-14:15 |
Discussion
|
| 14:15-14:45 |
Biomedical imaging
Professor Elizabeth HillmanColumbia University, US
Professor Elizabeth HillmanColumbia University, US Dr Elizabeth Hillman is Associate Professor of Biomedical Engineering and Radiology and a member of the Zuckerman Mind Brain Behavior Institute and Kavli Institute for Brain Science at Columbia University. Dr Hillman received her undergraduate training in Physics and PhD in Medical Physics and Bioengineering at University College London. She was a post-doctoral fellow and then junior faculty at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital/Harvard Medical School before joining Columbia University in 2006. Dr Hillman’s research program focuses on understanding the mechanisms of functional neurovascular coupling in the brain. Her lab also specializes in the design and development of novel optical imaging and microscopy techniques for capturing structure and function in the living brain. |
| 14:45-15:00 |
Discussion
|
| 15:00-15:30 |
Break
|
| 15:30-16:00 |
Nanoshell SERS for cancer detection
Professor Naomi HalasRice University, US
Professor Naomi HalasRice University, US Naomi J Halas is a University Professor and the Stanley C Moore Professor of Electrical and Computer Engineering at Rice University. She was the first person to introduce structural control into the synthesis of metal nanoparticles to control their optical properties. She is the author of over 400 refereed publications, has more than 30 issued patents, and has presented more than 650 invited talks. She co-founded Syzygy Plasmonics, a company currently deploying light-based chemical reactors based on photocatalyst particles originally invented in her laboratory. She is a member of the US National Academy of Sciences, the National Academy of Engineering, the American Academy of Arts and Sciences, the Royal Danish Academy of Sciences and Letters, and the Royal Society of Chemistry (UK). |
| 16:00-16:15 |
Discussion
|
| 16:15-17:00 |
Panel discussion
Dr Xavi Prieto
Dr Xavi Prieto |